Author Correction: Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial

Affiliations

¹ Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. toudou-nsu@umin.ac.jp.
² Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
³ Department of Data Science, National Center for Global Health and Medicine in Japan, Tokyo, Japan.
⁴ Leading Center for the Development and Research of Cancer Medicine, Juntendo University, Tokyo, Japan.
⁵ Department of Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
⁶ Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.

Published Erratum

Tomoki Todo et al. Nat Med. 2025 Apr.

. 2025 Apr;31(4):1365.

doi: 10.1038/s41591-025-03619-5.

¹ Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. toudou-nsu@umin.ac.jp.
² Division of Innovative Cancer Therapy, Advanced Clinical Research Center, and Department of Surgical Neuro-Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
³ Department of Data Science, National Center for Global Health and Medicine in Japan, Tokyo, Japan.
⁴ Leading Center for the Development and Research of Cancer Medicine, Juntendo University, Tokyo, Japan.
⁵ Department of Pathology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
⁶ Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.

No abstract available

Erratum for

Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.
Todo T, Ito H, Ino Y, Ohtsu H, Ota Y, Shibahara J, Tanaka M. Todo T, et al. Nat Med. 2022 Aug;28(8):1630-1639. doi: 10.1038/s41591-022-01897-x. Epub 2022 Jul 21. Nat Med. 2022. PMID: 35864254 Free PMC article. Clinical Trial.